Prognostic Value of Cathepsin D in Breast Cancer
Author Information
Author(s): A Losch, C Tempfer, P Kohlberger, EA Joura, M Denk, B Zajic, G Breitenecker, C Kainz
Primary Institution: University of Vienna
Hypothesis
What is the prognostic value of cathepsin D expression in breast cancer?
Conclusion
Cathepsin D expression in the epithelial component of breast cancer is associated with poor overall survival, but it does not provide additional prognostic information when considered with established factors.
Supporting Evidence
- Positive epithelial cathepsin D expression was found in 31.1% of patients.
- Cathepsin D expression was associated with stage and nuclear grade.
- Stromal cathepsin D expression showed no significant association with survival.
- Multivariate analysis revealed cathepsin D expression was not an independent predictor of outcome.
- Cathepsin D expression had significant prognostic value for overall survival and recurrence-free interval.
Takeaway
This study looked at a protein called cathepsin D in breast cancer and found that when it's present in the cancer cells, it can mean the patient might not do as well, but it doesn't help predict outcomes beyond what doctors already know.
Methodology
The study analyzed 103 paraffin-embedded tumor specimens from women with invasive ductal carcinoma, assessing cathepsin D expression using immunohistochemistry.
Potential Biases
There may be interobserver variability in the assessment of staining.
Limitations
The study's sample size was limited, and the analysis did not account for pre- and postmenopausal status or lymph node-positive and -negative patients in subgroup analysis.
Participant Demographics
The mean age of participants was 54 years, with a range from 23 to 81 years; 42 were premenopausal and 61 were postmenopausal.
Statistical Information
P-Value
0.003 and 0.01 for overall survival
Confidence Interval
1.1 (0.4-3.0) for CD+/TU
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website